Magenta Therapeutics (MGTA) PT Lowered to $15 at Wedbush, Following Earnings
Tweet Send to a Friend
Wedbush analyst David Nierengarten lowered the price target on Magenta Therapeutics (NASDAQ: MGTA) to $15.00 (from $20.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
